FimmCyte ApS: Financial statements 2024
CVR: 43432583
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
FimmCyte ApS (CVR 43432583) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -5,548,427 and a net result of DKK -5,454,290. Equity in the 2024 report amounted to DKK -8,966,396.
- Gross Profit
- DKK -5,548,427
- Profit/Loss
- DKK -5,454,290
- Equity
- DKK -8,966,396
- Total Assets
- DKK 6,705,439
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
FimmCyte ApS has published its interim report for the period August 9, 2022 to December 31, 2023.
About FimmCyte ApS
FimmCyte ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2022. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Mohaned Mohamed Ahmed Ali Shilaih and Valentina Vongrad. The company is owned by FimmCyte AG. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -3,405,028 and a net result of DKK -2,175,185 compared with DKK -5,454,290 the year before. Equity in the 2025 report amounted to DKK -11,141,581.